Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while obinutuzumab/venetoclax does not significantly alter blood viscosity.

Their prevalence and relatively long lifespan are in part why red blood cells are such an attractive target for scientists. Part of the challenge, Mitragotri said, would be ensuring cells aren't ...

Red blood cells provide your body with oxygen from the ... Because many chemotherapy treatments target rapidly dividing cells, hair loss is a common side effect of treatment.

Eating foods high in key nutrients, including iron, folic acid, and vitamin B12, and limiting alcohol may help increase your red blood cell count. Red blood cells are the most common cells in ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

Lung cancer is one of the leading causes of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for about ...

Nonetheless, recent evidence suggests that CCR7 is more than a facilitator of lymphatic spread of tumor cells. Here, we review published data to catalogue CCR7 expression across blood cancers and ...

Objective Neural tube defects (NTDs) are a preventable folate deficiency disorder; increasing folic acid intake through food ...

Here’s how it works. When modern humans journeyed out of Africa, a rapid evolution in their red blood cells may have helped them survive — but it may have also led to the eventual ...

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was injected directed into a human patient to treat hereditary blindness. The ...

Plasma is the liquid part of your blood. It’s made of water, proteins, clotting factors, hormones, and other substances. Floating in the plasma are many red blood cells (RBCs). These cells contain ...